Den europeiske union - engelsk - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressants - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique 10,844 mg - eq. atorvastatine 10 mg; macrogol 0,631 - comprimé pelliculé - 10 mg - atorvastatine calcique 10.84 mg - atorvastatin

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique trihydraté 21,688 mg - eq. atorvastatine 20 mg - comprimé pelliculé - 20 mg - atorvastatine calcique 21.69 mg - atorvastatin

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique trihydraté 43,376 mg - eq. atorvastatine 40 mg - comprimé pelliculé - 40 mg - atorvastatine calcique 43.38 mg - atorvastatin

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique trihydraté 86,751 mg - eq. atorvastatine 80 mg - comprimé pelliculé - 80 mg - atorvastatine calcique 86.75 mg - atorvastatin

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique trihydraté 21,688 mg - eq. atorvastatine 20 mg - comprimé pelliculé - 20 mg - atorvastatine calcique 20.72 mg - atorvastatin

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique trihydraté 43,376 mg - eq. atorvastatine 40 mg - comprimé pelliculé - 40 mg - atorvastatine calcique 41.44 mg - atorvastatin

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique trihydraté 86,751 mg - eq. atorvastatine 80 mg - comprimé pelliculé - 80 mg - atorvastatine calcique 82.88 mg - atorvastatin

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - atorvastatine calcique 10,844 mg - eq. atorvastatine 10 mg - comprimé pelliculé - 10 mg - atorvastatine calcique 10.36 mg - atorvastatin

Den europeiske union - rumensk - EMA (European Medicines Agency)

viatris limited - clopidogrel besilate - peripheral vascular diseases; stroke; myocardial infarction - agenți antitrombotici - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). supradenivelare de segment st infarct miocardic acut, în asociere cu aas în tratați medical, eligibili pentru tratamentul trombolitic. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. pentru informații suplimentare vă rugăm să consultați secțiunea 5.